
Overview
Zawamed is a company that conducts preclinical and clinical research, as well as training using in vitro models. They support clients in various industries, including cosmetics, feed, food, and pharmaceuticals, by assisting with funding acquisition, study design, execution, result interpretation, and report creation. Additionally, they provide services related to clinical trial cost settlements and patient compensation.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 647 days for 2021), 1 not filed.
- 2025not filed
- 202422/07/2025
- 2023not filed
- 202222/04/2024
- 202122/04/2024
- 202029/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2021. In 2022 it is performing 1 contract worth USD 20.41. All its contracts were worth USD 20.41 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2022 |
|---|---|---|---|
| Podstawowa Opieka Zdrowotna | mazowieckie | 1 | USD 20.41 |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wioletta Krakówka age 49 | 50 | $13,506.21 | 50% |
Piotr Roman Orłowski age 41 | 50 | $13,506.21 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-06-24.
34 1020 3802 0000 1402 0292 7549
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl | ||
| Ti-Com sp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Pharmaxi Poland sp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| ETG Network sp. z o.o. | $130,111.47 | etg-network.com | ||
| HTA Registry sp. z o.o. | $96,615.01 | htaregistry.pl | ||
| Medapp Clinical Research sp. z o.o. | $55,499.75 | medappclinicalresearch.pl | ||
| Biostat Research and Development sp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Biomedical Centers sp. z o.o. | $41,376.85 | biomedical-centers.com | ||
| Orphinic Scientific S.A. | $42,972.42 | orphinic.com | ||
| Biolabic sp. z o.o. | $37,688.85 | biolabic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-02-14 | Address change (Ul. Jana Olbrachta 19/38, 01-108, Warszawa → Ul. Marii Rodziewiczówny 9, 07-300, Ostrów Mazowiecka) | |
| 2024-02-14 | Share capital increase (5,000.00 PLN → 100,000.00 PLN) | |
| 2020-05-05 | Address change (61, 16-075, Targonie Wielkie → Ul. Jana Olbrachta 19/38, 01-108, Warszawa) | |
| 2020-05-05 | PKD change (Removed: 9 codes; Added: 8 codes) | |
| 2019-01-15 | Entered in the register |
FAQ
Last updated: 2026-04-10